faa glp 1 What Airline Pilots Need to Know About Weight-Loss Medications How GLP-1 medications are transforming

For those using GLP-1 receptor agonists primarily for weight management , there is similarly no physiological need to wean off the medication

After approving oral Wegovy in December 2025, the FDA has now also approved Clinical trial data shows that participants taking Foundayo achieved meaningful weight loss compared with placebo, reinforcing its potential as an effective treatment option

BMI plays an important role in determining eligibility for GLP-1 weight loss treatments, as it helps assess the degree of obesity and associated health risks

Also, one study is evaluating the effect of exenatide once weekly on Parkinsons disease progression by MRI (72)